The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study

[1]  A. Manni,et al.  Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar , 1991, Breast Cancer Research and Treatment.

[2]  S. Romain,et al.  Prognostic value of epidermal growth factor receptor in node-positive breast cancer , 1989, Breast Cancer Research and Treatment.

[3]  J. Foekens,et al.  Cell biological factors associated with the response of breast cancer to systemic treatment. , 1993, Cancer treatment reviews.

[4]  J. Foekens,et al.  The prognostic value of epidermal growth factor receptors determined both by immunohistochemistry and ligand binding assay, in primary epithelial ovarian cancer (OC) , 1993 .

[5]  J. Foekens,et al.  Prognostic factors and response to therapy in breast cancer. , 1993, Cancer surveys.

[6]  J. Foekens,et al.  Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. , 1992, Cancer research.

[7]  Y. Chiew,et al.  Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. , 1992, The Journal of biological chemistry.

[8]  J. Foekens,et al.  Clinical breast cancer, new developments in selection and endocrine treatment of patients , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  C. Osborne,et al.  Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor. , 1992, Cancer research.

[10]  M. Lynch,et al.  Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line. , 1992, British Journal of Cancer.

[11]  G. Scambia,et al.  Significance of epidermal growth factor receptor in advanced ovarian cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  T. Benraad,et al.  Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology. , 1992, European journal of cancer.

[13]  J G Klijn,et al.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.

[14]  J. Cairns,et al.  Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. , 1992, British Journal of Cancer.

[15]  J. Mendelsohn.  Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. , 1992, Journal of the National Cancer Institute. Monographs.

[16]  L. Skoog,et al.  Heterogenous expression of the EGF-receptor in human breast carcinoma. , 1992, Anticancer research.

[17]  J. Foekens,et al.  Six methods for direct radioiodination of mouse epidermal growth factor compared: effect of nonequivalence in binding behavior between labeled and unlabeled ligand. , 1991, Clinical chemistry.

[18]  W. L. McGuire,et al.  Breast cancer prognostic factors: evaluation guidelines. , 1991, Journal of the National Cancer Institute.

[19]  J. Farndon,et al.  Synthetic oligonucleotides as therapeutic agents. , 1991, British Journal of Cancer.

[20]  A. Harris,et al.  Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  A. Harris.  The epidermal growth factor receptor as a target for therapy. , 1990, Cancer cells.

[22]  J. Foekens,et al.  Hydroxyapatite Assay to Measure Epidermal Growth Factor Receptor in Human Primary Breast Tumours , 1990, Annals of clinical biochemistry.

[23]  J. Foekens,et al.  Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. , 1989, Cancer research.

[24]  P. Hasleton,et al.  Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival. , 1989, British Journal of Cancer.

[25]  E. Szabo,et al.  Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. , 1989, Cancer research.

[26]  J. Farndon,et al.  EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER , 1989, The Lancet.

[27]  J. Klijn,et al.  The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer , 1988, Cancer.

[28]  Atsushi Ochiai,et al.  Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma , 1988, International journal of cancer.

[29]  L. King,et al.  Role of epidermal growth factor in carcinogenesis. , 1986, Cancer research.

[30]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER , 1985, The Lancet.

[31]  M. Bennett,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS , 1985, The Lancet.

[32]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND ESTROGEN-RECEPTORS IN HUMAN-BREAST CANCER , 1985 .

[33]  J. Wittliff,et al.  Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. , 1984, Cancer research.